Nilesh B Chaudhari, Amar G Zalte, Vishal S Gulecha
Nilesh B Chaudhari1*, Amar G Zalte2, Vishal S Gulecha3
1,2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Sandip University, Nashik, India.
3Department of Pharmacology, School of Pharmaceutical Sciences, Sandip University, Nashik, India.
Volume - 16,
Issue - 3,
Year - 2023
Solid lipid nanoparticles (SLN) have engrossed snowballing consideration throughout recent years. This paper depicts an impression about the quality by design approach on formulation, optimization, characterization of solid lipid nanoparticles (SLN) loaded with Atorvastatin (AT). A unique microwave-assisted microemulsion technique of preparation was contemplated to formulate AT SLN. Optimization was executed using 32 response surface methodology where optimized the effect of Glyceryl monostearate (GMS) (X1) and Poloxamer 407 (X2) concentration as an independent variable on % entrapment efficiency (EE) (Y1) and particle size (Y2) as dependent variables. Characterization of optimized formulation was done by employing EE, particle size, Fourier transformed infrared spectroscopy (FTIR), X-ray diffraction (XRD), Differential Scanning Calorimetry (DSC), scanning electron microscopy (SEM), in vitro and ex vivo drug release. The percentages of EE fell within the range of 55 to 82%, particle size was in between the range of 290.3 to 890.4 nm and in vitro drug release was found to be 63.8% also ex vivo absorption was found to be 59.8 % for the duration of 8 hours. The AT SLN was successfully prepared and effective in releasing the drug in sustained mode.
Cite this article:
Nilesh B Chaudhari, Amar G Zalte, Vishal S Gulecha. Formulation, optimization, characterization and in vitro-ex vivo evaluation of atorvastatin loaded solid lipid nanoparticles using quality by design approach. Research Journal of Pharmacy and Technology 2023; 16(3):1433-1. doi: 10.52711/0974-360X.2023.00236
Nilesh B Chaudhari, Amar G Zalte, Vishal S Gulecha. Formulation, optimization, characterization and in vitro-ex vivo evaluation of atorvastatin loaded solid lipid nanoparticles using quality by design approach. Research Journal of Pharmacy and Technology 2023; 16(3):1433-1. doi: 10.52711/0974-360X.2023.00236 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-3-72
1. Yang S, Zhu J, Liang B, et al. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res. 1996,16,751-757. 10.1023/a:1018888927852.
2. Katkade PN. Formulation and evaluation of solid lipid nanoparticles of selected active pharmaceutical ingredients 2017 [PhD thesis].
3. Biswal S, Sahoo J , Murthy PN. Enhancement of Dissolution Rate of Gliclazide Using Solid Dispersions with Polyethylene Glycol 6000. AAPS Pharm SciTech. 2008; 9(2), 563-570.
4. Chakraborty S, Shukla D, Mishra B. Lipid: An emerging platform for oral delivery of drugs with poor bioavailability. European Journal of Pharmaceutics and Biopharmaceutics. 2009; 73 (1), 1-15. 10.1016/j.ejpb.2009.06.001.
5. Potta SG, Minemi S, Nukala RK, et al. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. J Biomed Nanotechnol. 2010; 6(6),634-40. 10.1166/jbn.2010.1169.
6. Mukherjee S, Ray S, Thakur RS. Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System. Indian Journal of Pharmaceutical Sciences. 2009; 71(4),349-358. 10.4103/0250-474X.57282.
7. Kadam RS, Bourne D, Kompella UB. Nano- Advantage in Enhanced Drug Delivery with Biodegradable Nanoparticles: Contribution of Reduced Clearance. Drug Metabolism and Disposition. 2012; 40(7), 1380-1388. 10.1124/dmd.112.044925.
8. Yildirimer L, Thanh N, Loizidou M, et al, 2011. Toxicology and clinical potential of nanoparticles. Nano Today 6(6), 585-607. 10.1016/j.nantod.2011.10.001.
9. Dhome AG, Deshkar SS, Shirolkar SV. Gliclazide solid lipid nanoparticles formulation, optimization and in vitro characterization. Pharmaceutical resonance. 2018; 1(1), 8-16.
10. Urban-Morlan Z, Ganem-Rondero A , Melgoza- Contreras LM, et al, 2010. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification- diffusion method. Int J Nanomedicine 5, 611-20. 10.2147/IJN.S12125
11. Shah RM, Eldridge DS ,Palombo EA, et al. Encapsulation of clotrimazole solid lipid nanoparticles by microwave assisted microemulsion technique. Applied materials today. 2016; 5, 118-127. 10.1016/j.apmt.2016.09.010.
12. Souza LG, Silva EJ, Martins AL, et al. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur J Pharm Biopharm. 2011; 79 (1), 189-96. 10.1016/j.ejpb.2011.02.012
13. Silva AC, Gonzalez-Mira E, Garcia ML , et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B Biointerfaces. 2011; 86(1), 158-65. 10.1016/j.colsurfb.2011.03.035.
14. Chaudhari NB, Zalte AG, Gulcha VS. Advanced technologies in the preparation of solid lipid nanoparticles: a review. Journal of Seybold report. 2020; 25(10), 414-425.
15. Pandya BJ , Parmar RD, Soniwala MM, et al. Solid Lipid Nanoparticles: Overview on Excipients. Asian Journal of Pharmaceutical Technology & Innovation. 2013; 1 (3). 1-9.
16. Ekambaram P , Sathali AH , Priyanka K. Solid Lipid Nanoparticles: A Review. Scientific Reviews and Chemical. Communication Suppl 1. 2012; 80-102.
17. Vogel. Textbook of Quantitative Chemical Analysis. ELBS Longman, London 5 th edition, 1997; 661-672.
18. Miller JC, Miller JN. In: Statistics for Analytical Chemistry. 1984;2nd ed, Wiley, New York, 83–11.
19. Indian Pharmacopoeia, Vol –II, Government of India, Ministry of Health and Family Welfare,The controller of publications, New Delhi. 2007;599-600.
20. British Pharmacopoeia. Vol -I ,Department of Health London: The Stationary Office 2009: 232, 489, 1048-1050.
21. United State Pharmacopoeia, 31st edition, US convection INC, Rock Ville, 2008:1193, 2373.
22. Shirsath NR, Goswami AK. vildagliptin loaded gellan gum mucoadhesive beads for sustained drug delivery: design, optimization and evaluation. Material technology advanced performance materials. Taylor & Francis. 2020;1-15. 10.1080/10667857.2020.1786783.
23. Fernanda IB, Fabiola GP, Beatriz S. Gellan gum microspheres crosslinked with trivalent ion: effect of polymer and crosslinker concentrations on drug release and mucoadhesive properties. Drug Dev Ind Pharm. 2015; 42,9045–9051. 10.3109/03639045.2015.1125915
24. Kumar A, Pal D , Santra K. Artocarpus heterophyllus L seed starch-blended gellan gum mucoadhesive beads of metformin HCl. Int J Biol Macromol. 2014; 65,329–339. 10.1016/j.ijbiomac.2014.01.022
25. Singh B, Sharma V , Chauhan D. Gastroretentive floating sterculia – alginate beads for use in antiulcer drug delivery. Chem Eng Res Des. 2010; 8, 997–1012. 10.1016/j.cherd.2010.01.017
26. Naik JB , Waghulde MR,. Development of vildagliptin loaded - by screening design : in vitro evaluation. J Pharm Investig. 2018; 48, 627–637.
27. Schmink JR, LeadbeaterNE. Microwave heating as a tool for sustainable chemistry, Microwave heating as a tool for sustainable chemistry. CRC Press. USA, 2014; pp. 1-24.
28. Sharma S, Kanugo A, Gaikwad J. Design and development of solid lipid nanoparticles of tararotene for the treatment of psoriasis and acne: a quality by design approach. Material technology advanced performance materials. Taylor & Francis, 2020;1-20. 10.1080/10667857.2021.1873637
29. Patil J, Rajput R, Nemade R et al. Preparation and characterization of artemether loaded solid lipid nanoparticles; a 32 factorial design approach. 2018;1-20. 10.1080/10667857.2018.1475142.